Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,423 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hand-foot-skin reaction of grade ≥ 2 within sixty days as the optimal clinical marker best help predict survival in sorafenib therapy for HCC.
Wang E, Xia D, Bai W, Wang Z, Wang Q, Liu L, Wang W, Yuan J, Li X, Chen H, Lv Y, Niu J, He C, Guo W, Yin Z, Luo B, Han N, Wang Z, Yu T, Yuan X, Li K, Tie J, Li C, Cai H, Xia J, Fan D, Han G. Wang E, et al. Among authors: wang w, wang z, wang q. Invest New Drugs. 2019 Jun;37(3):401-414. doi: 10.1007/s10637-018-0640-7. Epub 2018 Jul 18. Invest New Drugs. 2019. PMID: 30019101
Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis: a randomised controlled trial.
Lv Y, Yang Z, Liu L, Li K, He C, Wang Z, Bai W, Guo W, Yu T, Yuan X, Zhang H, Xie H, Yao L, Wang J, Li T, Wang Q, Chen H, Wang E, Xia D, Luo B, Li X, Yuan J, Han N, Zhu Y, Niu J, Cai H, Xia J, Yin Z, Wu K, Fan D, Han G; AVB-TIPS Study Group. Lv Y, et al. Among authors: wang e, wang z, wang j, wang q. Lancet Gastroenterol Hepatol. 2019 Aug;4(8):587-598. doi: 10.1016/S2468-1253(19)30090-1. Epub 2019 May 29. Lancet Gastroenterol Hepatol. 2019. PMID: 31153882 Clinical Trial.
Sorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells.
Hu J, Wang E, Liu L, Wang Q, Xia D, Bai W, Tie J, Li X, Yuan J, Yang S, Jiang D, Shi J, Sun Y, Wang J, Zhang C, Niu J, Li K, He C, Guo W, Lv Y, Chen H, Yuan X, Yu T, Wang Z, Luo B, Han N, Zhu Y, Yin Z, Fan D, Zhang Z, Yang K, Han G. Hu J, et al. Among authors: wang e, wang j, wang z, wang q. Invest New Drugs. 2020 Oct;38(5):1247-1256. doi: 10.1007/s10637-019-00885-2. Epub 2019 Dec 13. Invest New Drugs. 2020. PMID: 31832851 Clinical Trial.
8,423 results